151 related articles for article (PubMed ID: 38506539)
1. Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
Takahashi T
AJR Am J Roentgenol; 2024 May; 222(5):e2431070. PubMed ID: 38506539
[No Abstract] [Full Text] [Related]
2. Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
de Oliveira Correia ET; Purysko AS; Paranhos BM; Shoag JE; Padhani AR; Bittencourt LK
AJR Am J Roentgenol; 2024 May; 222(5):e2431168. PubMed ID: 38506544
[No Abstract] [Full Text] [Related]
3. MR Imaging for Prostate Cancer Screening and Active Surveillance.
Druskin SC; Macura KJ
Radiol Clin North Am; 2018 Mar; 56(2):251-261. PubMed ID: 29420980
[TBL] [Abstract][Full Text] [Related]
4. Community-Based Screening for Prostate Cancer: A Role for Magnetic Resonance Imaging?
Lee SI; O'Shea A
JAMA Oncol; 2021 Mar; 7(3):402-403. PubMed ID: 33570559
[No Abstract] [Full Text] [Related]
5. Screening and detection advances in magnetic resonance image-guided prostate biopsy.
Stephenson SK; Chang EK; Marks LS
Urol Clin North Am; 2014 May; 41(2):315-26. PubMed ID: 24725492
[TBL] [Abstract][Full Text] [Related]
6. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
Fulgham PF; Rukstalis DB; Turkbey IB; Rubenstein JN; Taneja S; Carroll PR; Pinto PA; Bjurlin MA; Eggener S
J Urol; 2017 Oct; 198(4):832-838. PubMed ID: 28483574
[TBL] [Abstract][Full Text] [Related]
7. Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
Godtman RA; Pettersson C; Svensson L; Kohestani K; Stinesen Bratt K; Wallström J; Månsson M; Hellström M; Hugosson J
Eur Urol Oncol; 2024 Jun; 7(3):553-562. PubMed ID: 37993370
[TBL] [Abstract][Full Text] [Related]
8. Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro).
Maffei D; Giganti F; Moore CM
Urol Oncol; 2023 Feb; 41(2):88-91. PubMed ID: 35871993
[TBL] [Abstract][Full Text] [Related]
9. MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer.
Yin H; Shao J; Song H; Ding W; Xu B; Cao H; Wang J
Technol Cancer Res Treat; 2021; 20():15330338211019418. PubMed ID: 34013808
[TBL] [Abstract][Full Text] [Related]
10. MRI to guide biopsies or avoid biopsies?
Winoker JS; Pinto PA; Rastinehad AR
Curr Opin Urol; 2018 Nov; 28(6):522-528. PubMed ID: 30239414
[TBL] [Abstract][Full Text] [Related]
11. Rethinking prostate cancer screening: could MRI be an alternative screening test?
Eldred-Evans D; Tam H; Sokhi H; Padhani AR; Winkler M; Ahmed HU
Nat Rev Urol; 2020 Sep; 17(9):526-539. PubMed ID: 32694594
[TBL] [Abstract][Full Text] [Related]
12. Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
Takahashi T
Radiology; 2023 Nov; 309(2):e231177. PubMed ID: 37962502
[No Abstract] [Full Text] [Related]
13. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.
Vickers A; Carlsson SV; Cooperberg M
Eur Urol; 2020 Sep; 78(3):304-306. PubMed ID: 32389443
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography-The IP1-PROSTAGRAM Study-Reply.
Eldred-Evans D; Ahmed HU
JAMA Oncol; 2021 Oct; 7(10):1575-1576. PubMed ID: 34410324
[No Abstract] [Full Text] [Related]
16. How MRI is changing prostate cancer management: a focus on early detection and active surveillance: Comment l'IRM est en train de révolutionner la prise en charge du cancer de la prostate : focus sur la détection précoce et la surveillance active.
Fiard G; Giganti F
Prog Urol; 2022 Jun; 32(6S1):6S19-6S25. PubMed ID: 36719642
[TBL] [Abstract][Full Text] [Related]
17. A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
Nam RK; Wallis CJ; Stojcic-Bendavid J; Milot L; Sherman C; Sugar L; Haider MA
J Urol; 2016 Aug; 196(2):361-6. PubMed ID: 26880413
[TBL] [Abstract][Full Text] [Related]
18. How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
Vickers AJ; Russo G; Lilja H; Evans C; Schalken JA; Klein E; Eggener S
Eur Urol Oncol; 2022 Apr; 5(2):135-137. PubMed ID: 33608234
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and potential of an MRI-based prostate cancer screening.
Masone MC
Nat Rev Urol; 2023 Oct; 20(10):578. PubMed ID: 37696943
[No Abstract] [Full Text] [Related]
20. A Pragmatic Approach to Prostate Cancer Screening.
Tosoian JJ; Penson DF; Chinnaiyan AM
JAMA; 2024 May; 331(17):1448-1450. PubMed ID: 38581253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
